Online rush helps Keypath beat revenues forecast during float
MELBOURNE: Booming demand for courses in nursing and allied health and the “normalisation” of online… read more
Mesoblast could need another COVID trial says CEO
MELBOURNE: Losses at stem cell treatments producer Mesoblast have hit $US98.8 million ($135 million) for… read more
Healius eyes M&A after sales surge says CEO
MELBOURNE: Healius boss Malcolm Parmenter says the healthcare giant is seeking to make bolt-on purchases… read more
16 new senior healthcare executives sought for key roles
MELBOURNE: Sixteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
